Multicentric evaluation of model for end-stage liver disease-based allocation and survival after liver transplantation in Germany - Limitations of the 'sickest first'-concept

Transplant International

Volumn 24, Issue 1, 2011, Pages 91-99

  Weismüller, Tobias J ^a   Fikatas, Panagiotis ^b   Schmidt, Jan ^c   Barreiros, Ana P ^d   Otto, Gerd ^d   Beckebaum, Susanne ^e   Paul, Andreas ^e   Scherer, Markus N ^f   Schmidt, Hartmut H ^g   Schlitt, Hans J ^f   Neuhaus, Peter ^b   Klempnauer, Jürgen ^a   Pratschke, Johann ^b   Manns, Michael P ^a   Strassburg, Christian P ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

choline esterase; hepatocellular carcinoma; hyponatremia; liver transplantation; model for end stage liver disease; organ allocation; survival

Indexed keywords

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; GERMANY; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FEMALE; GERMANY; HEALTH CARE RATIONING; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 78650032731     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2010.01161.x     Document Type: Article

References (24)

1. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91.
2. Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537.
3. Cholongitas E, Marelli L, Shusang V, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12: 1049.
4. Nagler E, Van Vlierberghe H, Colle I, Troisi R, De Hemptinne B,. Impact of MELD on short-term and long-term outcome following liver transplantation: a European perspective. Eur J Gastroenterol Hepatol 2005; 17: 849.
5. Weismuller TJ, Prokein J, Becker T, et al. Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008; 43: 736.
6. Waki K,. UNOS Liver Registry: ten year survivals. Clin Transpl 2006: 29.
7. Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004; 77: 99.
8. Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transpl 2007; 13: 1174.
9. Ferraz-Neto BH, Zurstrassen MP, Hidalgo R, et al. Analysis of liver transplantation outcome in patients with MELD Score > or = 30. Transplant Proc 2008; 40: 797.
10. Dellon ES, Galanko JA, Medapalli RK, Russo MW,. Impact of dialysis and older age on survival after liver transplantation. Am J Transplant 2006; 6: 2183.
11. Weismuller TJ, Negm A, Becker T, et al. The introduction of MELD-based organ allocation impacts 3-month survival after liver transplantation by influencing pretransplant patient characteristics. Transpl Int 2009; 22: 970.
12. Freeman RB Jr,. Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 2008; 47: 1052.
13. Ahmad J, Downey KK, Akoad M, Cacciarelli TV,. Impact of the MELD score on waiting time and disease severity in liver transplantation in United States veterans. Liver Transpl 2007; 13: 1564.
14. De La Mata M, Cuende N, Huet J, et al. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a spanish multicenter experience. Transplantation 2006; 82: 1429.
15. Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology 2006; 130: 1652.
16. Young AL, Rajagenashan R, Asthana S, et al. The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom. Transpl Int 2007; 20: 331.
17. Londono MC, Cardenas A, Guevara M, et al. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut 2007; 56: 1283.
18. Huo TI, Lee SD, Lin HC,. Selecting an optimal prognostic system for liver cirrhosis: the model for end-stage liver disease and beyond. Liver Int 2008; 28: 606.
19. Dawwas MF, Lewsey JD, Neuberger JM, Gimson AE,. The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study. Liver Transpl 2007; 13: 1115.
20. Londono MC, Guevara M, Rimola A, et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. Gastroenterology 2006; 130: 1135.
21. Yun BC, Kim WR, Benson JT, et al. Impact of pretransplant hyponatremia on outcome following liver transplantation. Hepatology 2009; 49: 1610.
22. Volk ML, Lok AS, Pelletier SJ, Ubel PA, Hayward RA,. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology 2008; 135: 1568.
23. Bonney GK, Aldersley MA, Asthana S, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation 2009; 87: 1858.
24. Schaubel DE, Guidinger MK, Biggins SW, et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009; 9: 970.